| HOME >> MEDICINE >> TECHNOLOGY |
Bristol-Myers Squibb Medical Imaging Changes Name to Lantheus
Medical Imaging 71
Bayer Schering Secures FDA Marketing Clearance for Primovist® 72
Bracco-Eisai Secures Approval for Iomeron® 350 and Iomeron®
350 Syringe for Use in Dynamic Liver CT 72
Covidien Signs Co-Marketing Deal with PETNET over Nuclear
Medicine Therapies 73
EPIX Receives FDA Approval for Vasovist 74
GE Global and NCI Partner to Speed-up Development of Cancer
and Heart Disease Diagnosing Nanoparticle Imaging Agents 74
Lantheus Wins Contract from PPP 75
Sanguine to Take over Rockland 75
Starpharma Holdings Enters into an Agreement with Unilever 75
GE Healthcare and Cardinal Health Enter Into a Deal 75
Jubilant to Take Over DRAXIS 76
MTTI and Bexion to Partner for Nanovesicle 76
Otsuka Takes over IPP 76
Wilex Inks Deal with IBA 77
Cytogen Corporation to Merge Business with EUSA Pharma Inc 77
Bracco Group Acquires E-Z-EM 77
EPIX Pharmaceuticals to Resubmit New Drug Application (NDA)
for Vasovist 77
Bayer Schering, FutureChem Ink Licensing Deal 78
NuView Radio Pharmaceuticals Inks Agreement for Non- Invasive
Imaging Agent 78
11. CORPORATE ACTIVITY IN RECENT PAST - A PERSPECTIVE BUILDER 79
Advanced Magnetics Inc Changes Name to AMAG Pharmaceuticals 79
Bracco Diagnostics Inks Agreement with HealthTrust Purchasing
Group 79
Bracco Diagnostics Offers MRI Products to HealthTrust
Purchasing Group 79
Bayer HealthCare Offers MRI Contrast Agent to HealthTrust 79
Bayer HealthCare Extends Contract with Premier 79
Bayer HealthCare Sets Off US Operations 79
Tyco Healthcare Renamed to Covidien Ltd 80
Covidien Offers Imaging Solutions to MedAssets Supply Chain
Systems 80
Siemens, M.D. Anderson Cance
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |